Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-6 of 6
Keywords: Rosuvastatin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2012) 123 (3): 160–167.
Published Online: 31 October 2012
...Valerio Zacà; Sudhish Mishra; Ramesh C. Gupta; Sharad Rastogi; Hani N. Sabbah Objective: The objective of this study was to investigate the potential pleiotropic effects of rosuvastatin (RSV) in the left ventricular (LV) myocardium of dogs with moderate heart failure (HF). Methods: LV tissue...
Journal Articles
Journal:
Cardiology
Cardiology (2011) 120 (2): 84–88.
Published Online: 02 December 2011
...Victor L. Serebruany Objective: To compare all-cause mortality in JUPITER with other statin trials at 21 months of follow-up. Background: Outcome advantages including all-cause mortality reduction yielded from the JUPITER trial support aggressive use of rosuvastatin and, perhaps by extension, other...
Journal Articles
Subject Area:
Cardiovascular System
Ole Faergeman, Laurie Hill, Eberhard Windler, Olov Wiklund, Roland Asmar, Emma Duffield, Froukje Sosef
Journal:
Cardiology
Cardiology (2008) 111 (4): 219–228.
Published Online: 23 April 2008
... to optimal effect. The ECLIPSE study was designed to compare the efficacy and safety of force-titrated treatment with rosuvastatin (10–40 mg) with that of atorvastatin (10–80 mg) in high-risk patients with hypercholesterolemia. Methods: In this 24-week, open-label, randomized, multinational, parallel-group...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2007) 107 (4): 433–443.
Published Online: 16 March 2007
...James Shepherd; Donald G. Vidt; Elinor Miller; Susan Harris; James Blasetto Background: The safety and tolerability of rosuvastatin were assessed using data from 16,876patients who received rosuvastatin 5–40 mg in a multinational phase II/III / IIIb/IV program, representing 25,670 patient-years...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2004) 102 (1): 52–60.
Published Online: 28 April 2004
... of hyperlipidemic patients enrolled in the rosuvastatin (Crestor ® ) clinical development program permitted assessment of its effects on renal function both early and later in the course of treatment. Study participants were initially included in controlled clinical trials that evaluated the lipid-lowering efficacy...
Journal Articles
Subject Area:
Cardiovascular System
Journal:
Cardiology
Cardiology (2003) 99 (3): 126–139.
Published Online: 27 June 2003
...Herbert Schuster Rosuvastatin (Crestor ® ; licensed to AstraZeneca, Macclesfield, UK from Shionogi, Osaka, Japan) is a new statin with pharmacologic characteristics that translate into selectivity of effect in hepatic cells and enhanced potency in 3-hydroxy-3-methylglutaryl coenzyme A reductase...